Contenido | Anterior | Siguiente
Referencias
17. Maciejowska E, et al. Is pemphigus herpetiformis an entity? Int J Dermatol 1987;26:571-577.
18. Santi CG, Díaz LA et al. Pemphigus Herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo salvagem and pemphigus vulgaris. J Am Acad Dermatol 1996;34:40-46.
19. Wallach D, et al. Pustolose sous-cornée acantholyse superficielle et Ig A monoclonale. Ann Dermatol Venereol 1982;109:959-963.
20. Wallach D. Intrapermidermal IgA pustolosis, J Am Acad Dermatol 1992;27:993-1000.
21. Beutner EH, et al. Ig A pemphigus foliaceus: report of two cases and a review of the literature. J Am Acad Dermatol 1989;20:89-97.
22. Wang J, et al. Nonsecretory IgA 1 autoantibodies targeting desmosomal component desmoglein 3 in intrepidermal neutrophilic IgA dermatosis. Am J Pathol 1997;150:1901-1907.
23. Anhalt GJ, et al. Paraneoplastic pemphigus: an autoinmmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323: 1729-1735.
24. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997;12:77-96.
25. Kaplan RP, et al. Pemphigus associated disease an induced pemphigus. Clin Dermatol 1983;1(2): 62-71.
26. Vidal J. Pénfigo y Penfigoide. Actas Dermo Sif 1993;84:54-62.
27. Zone J, et al. Penicillamine induced pemphigus. JAMA 1982;247:2705-2707.
28. Merlub P, et al. Neonatal pemphigus vulgaris. Pediatric. 1986;78: 1102-1105.
29. Ross M, et al. Pemphigus in pregnancy an evaluation of fetal risk. Ann J Obstet Gynecol 1986;155:30-33.
30. Walker Dc, et al. Neonatal pemphigus foliaceus. Arch Dermatol 1995;131:1308.
31. Terpstra H. et al. In vivo bound pemphigus antibodies in a stillborn infant. Arch Dermatol 1979;115:316-319.
32. Wasserstrum N. et al. Transplasental transmission of pemphigus
JAMA 1983;249:1480-1482.
33. Wojnarowska F. et al. Eds. Management of Blistering Diseases. New York. Raven Press. 1990,43-61.
34. Kanwar AJ. et al. Further experience with pemphigus in children. Pediatr Dermatol 1996:11:107.
35. Smitt JHS. Pemphigus vulgaris in childhood: clinical features treatment and prognosis. Pediatr Dermatol 1985;2:185-190.
36. Ahmed AP. Salmon M. Juvenile pemphigus. J Am Acad Dermatol 1983;8:799-807.
37. Ebihara T. et al. Autoantigens for Ig A anti-intercellular antibodies of intercellular IgA vesiculopustular dermatosis. J Invest Dermatol 1991;97:742-745.

 

38. Ackerman BA. Histologic Diagnosis of Inflammatory Skin Diseases. Lea & Febiger. 1978:525-537.
39. Beutner EH. et al. Autoantibodies in pemphigus vulgaris. Response to an intercellular substance of epidermis. JAMA 1965;92:682-688.
40. Hashimoto T. et al. Studies of autoantigens recognized by Ig A anti-keratinocyte cell surface antibodies. J Dermatol Sci 1996;12:10-7.
41. Burdett IDJ. Aspects of structure and assembly of desmosomas. Micron 1998;29:309-328.
42. Fried R. et al. Paraneoplastic pemphigus appearing as bullous pemphigoid like eruption after pallative radiation therapy. J Am Acad Dermatol 1995;33:312-315.
43. Camisa C. et al. Paraneoplastic pemphigus is a distinct neoplasia-induced autoinmmune disease. Arch Dermatol 1993;129:883-886.
44. Savim. JA. The events leading to the death of patients with pemphigus and pemphigoid. Br J Dermatol 1979;101:521-534.
45. Krain LS. Biermann SM. Pemphigus vulgaris and internal malignancy. Cancer 1974;33:1091-1099.
46. Rosenberg FR. et al. Pemphigus a 20 year review of 107 patients treated with corticosteroids. Arch. Dermatol. 1976;112:962-970.
47. Ratnam KV. et al. Pemphigus therapy with oral prednisolone regimens. A 5 year study. In J Dermatol 1990;29:363.
48. Ahmed AR. May P. Death in pemphigus. J Am Acad Dermatol 1982;7:
221-228.
49. Lever WF. et al. Inmmunosupressants and prednisone in pemphigus vulgaris. Therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol 1977;
113:1236-1241.
50. Combes FC, Cañizares O. Pemphigus vulgaris. A clinicopathological study of one hundred cases. Arch Dermatol 1950;62:786-802.
51. Eller JJ, Kest LH. Pemphigus report of seventy-seven cases. Arch Dermatol 1941;44:337-344.
52. Bystrin JC. Adjuvant therapy of pemphigus. Arch Dermatol 1984; 120:941-951.
53. Lever WF. et al. Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of eleven years. Arch Dermatol 1963;87:12-26.
54. Bystryn JC. et al. The adjuvant therapy of pemphigus an update. Arch. Dermatol. 1996;132:203-212.
55. Wood A. Management of acquired bullous skin diseases. Review article. N Eng J Med 1995;333(2):1475-1484.
PENFIGOIDE

1. Korman NG. Bullous Pemphigoid Arch. Dermatol 1993;11(3): 497-513.

2. Lever’s WF. et al. Histopathology of the skin. Lippincot-raven. Philadelphia New York 8th edition. 1997;
3. Bernard P. et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three french regions. Arch Dermatol. 1995;131:48-52.
4. Ackerman BA. Histologic Diagnosis of Inflammatory Skin Diseases. Lea & Febiger. 1978;613-615.
5. Wojnarowska F. et al. Eds. Management of Blistering Diseases. New York. Raven Press 1990;63-82.
6. Anhalt GJ. Bullous and cicatricial pemphigoid. Dermatologic clinics 1990;8(4):701-716.
7. Stanley J. Bullous pemphigoid. Dermatologic Clinics 1983;205:10-12.
8. Fitzpatrick’s et al. Dermatology in General Medicine. New York. McGraw Hill. 5th edition. 1999;(1):667-673.
9. Hadi S, Barnetson R, et al. Clinical and histological studies in 50 patients with bullous pemphigoid Dermatológica 1998;176:6.
10. Harish P. Patel. Bullous pemphigoid. Current therapy in dermatology 21st ed. 58 BC Decker Inc. Philadelphia PA 1988.
11. Lindelof B, et al. Pemphigoid and Cancer Arch Dermatol 1990;126:66-67.
12. Montgomery H. Dermatopathology. Bullous Dermatoses. Hoeber Medical Division 1967;155.
13. Chan L. et al. Pemphigoid vegetans represents a bullous pemphigoid variant. J Am Acad Dermatol 1993; 28(2):331-335.
14. Ogasawara M. et al. Pemphigoid vegetans J Am Acad Dermatol 1994; 30:649-650.
15. Han-Nan H. et al. Clinical variants of pemphigoid. Int J Dermatol 1986; 25:17-18.
16. Tamada Y. et al. Pemphigoid nodularis. A case with 230 kD hemidesmosomes antigen associated with bullous pemphigoic antigen. J Dermatol 1995;22:201-204.
17. Rodenas J. et al. Penfigoide Nodular, una variedad atípica de penfigoide ampolloso. A propósito de un caso. Actas Dermo Sif 1996;87:321-25.
18. Cliff S. et al. Pemphigoid nodular: a report of three cases and review of the literature. Br J Dermatol 1997; 136:398-401.
19. Ross J. et al. Unusual variants of pemphigoid: from pruritus to pemphigoid nodularis. J Cutan Pathology 1992;19:212-216.
20. Gruber C. et al. Vesicular pemphigoid. J Am Acad Dermatol 1980; 3(6):619-622.
21. Buhac J, et al. Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid. J Am Acad Dermatol 1996;34:884-6.
22. Kim B. Yancy. Advances in the diagnosis of supediermal bullous diseases. Arch Dermatol 1996;132:220-222.
23. Shimizu H. et al. A comparative inmmunoelectrone microscopic study of tipical and atypical cases of pemphigoid. Br J Dermatol 1988;119:717-722.